---
figid: PMC6678135__cells-08-00674-g007
figtitle: Compounds that inhibit and activate autophagy
organisms:
- NA
pmcid: PMC6678135
filename: cells-08-00674-g007.jpg
figlink: /pmc/articles/PMC6678135/figure/cells-08-00674-f007/
number: F7
caption: 'Compounds that inhibit and activate autophagy. Autophagy inhibitors: 3-methyladenine
  inhibits PI3K. Bafilomycin A1 causes dissociation of the Beclin 1-Vps34 complex
  and prevents the formation of autolysosome. Chloroquine/hydroxychloroquine, NH4Cl,
  and leupeptin rapidly neutralizing the acidic environment of the lysosome and are
  used to block lysosomal degradation of substrates. Leupeptin inhibits cysteine,
  serine and threonine peptidases, and hence blocking protein degradation at the last
  step of autophagy. Autophagy activators: rapamycin inhibits the mTOR. RAD001 and
  AP23573 are rapamycin derivatives having comparatively higher safely with minimum
  dose toxicities. Trehalose causes LC3-I to LC3-II conversion in an mTOR-independent
  pathway. Valproic acid increases LC3-II and Beclin 1 concentrations.'
papertitle: 'A Comprehensive Review of Autophagy and Its Various Roles in Infectious,
  Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease
  Prevention, Novel Drug Design, and Therapy.'
reftext: Rekha Khandia, et al. Cells. 2019 Jul;8(7):674.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9083657
figid_alias: PMC6678135__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6678135__F7
ndex: 30041255-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6678135__cells-08-00674-g007.html
  '@type': Dataset
  description: 'Compounds that inhibit and activate autophagy. Autophagy inhibitors:
    3-methyladenine inhibits PI3K. Bafilomycin A1 causes dissociation of the Beclin
    1-Vps34 complex and prevents the formation of autolysosome. Chloroquine/hydroxychloroquine,
    NH4Cl, and leupeptin rapidly neutralizing the acidic environment of the lysosome
    and are used to block lysosomal degradation of substrates. Leupeptin inhibits
    cysteine, serine and threonine peptidases, and hence blocking protein degradation
    at the last step of autophagy. Autophagy activators: rapamycin inhibits the mTOR.
    RAD001 and AP23573 are rapamycin derivatives having comparatively higher safely
    with minimum dose toxicities. Trehalose causes LC3-I to LC3-II conversion in an
    mTOR-independent pathway. Valproic acid increases LC3-II and Beclin 1 concentrations.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATG5
  - ATG7
  - ATG10
  - ATG3
  - ATG4A
  - ATG4B
  - ATG4C
  - ATG4D
  - ATG12
  - MAP1LC3A
  - ADRA1D
  - DYNLL1
  - PIK3C3
  - SH3GLB1
  - ATG14
  - UVRAG
  - BECN1
  - PIK3R4
  - ATG13
  - MTOR
  - RB1CC1
  - ULK1
  - ULK2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - Valproic acid
  - Bafilomycin
  - Trehalose
  - Chloroquine
  - Rapamycin
  - AP23573
  - 3-methyladenine
---
